Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A
Amy D ShapiroIndiana Hemophilia and Thrombosis Center, Indianapolis, IN, USAAbstract: Removal of blood-based additives from recombinant clotting factor concentrates continues to be advocated by the hemophilia community due to the history of infectious disease transmission with previous blood-derived...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2007-11-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/anti-hemophilic-factor-recombinant-plasmaalbumin-free-method-octocog-a-peer-reviewed-article-VHRM |